Free Trial
→ This stock just surpassed Palantir (From InvestorPlace) (Ad)tc pixel Free GANX Stock Alerts

Gain Therapeutics (GANX) Institutional Ownership

Gain Therapeutics logo
$1.73 +0.02 (+1.17%)
Closing price 04:00 PM Eastern
Extended Trading
$1.73 0.00 (0.00%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Gain Therapeutics (NASDAQ:GANX)

Current
Institutional Ownership
Percentage
11.97%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$1.16M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$390.93K
Get GANX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GANX Institutional Buying and Selling by Quarter

Gain Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2025Marshall Wace LLP276,433$498K0.0%+41.0%0.919%
8/8/2025Geode Capital Management LLC290,462$523K0.0%+2.9%0.966%
5/13/2025Kovitz Investment Group Partners LLC47,578$91K0.0%N/A0.162%
5/7/2025Dauntless Investment Group LLC125,584$240K0.3%N/A0.427%
2/17/2025Gotham Asset Management LLC158,155$342K0.0%-52.7%0.596%
2/17/2025Bridgeway Capital Management LLC30,004$65K0.0%N/A0.113%
2/14/2025Northern Trust Corp84,586$183K0.0%+88.2%0.319%
2/13/2025Marshall Wace LLP91,738$198K0.0%N/A0.346%
2/12/2025Geode Capital Management LLC267,421$578K0.0%-1.7%1.008%
2/6/2025Jones Financial Companies Lllp98,250$212K0.0%+83.6%0.370%
2/4/2025Sprott Inc.14,000$30K0.0%N/A0.053%
1/28/2025Benedict Financial Advisors Inc.16,000$35K0.0%N/A0.060%
11/16/2024Geode Capital Management LLC271,972$484K0.0%+48.0%1.065%
8/9/2024Renaissance Technologies LLC118,700$152K0.0%+154.2%0.658%
8/9/2024Warberg Asset Management LLC51,600$66K0.0%N/A0.286%
8/3/2024Hohimer Wealth Management LLC330,000$422K0.1%N/A1.828%
1/16/2024Raymond James & Associates23,788$78K0.0%-29.6%0.184%
7/25/2023Raymond James & Associates33,400$150K0.0%+67.0%0.271%
5/8/2023CM Management LLC90,000$434K0.5%-18.2%0.740%
5/2/2023Wealth Alliance Advisory Group LLC12,502$60K0.0%-33.3%0.105%
4/14/2023Raymond James & Associates20,000$96K0.0%-16.7%0.168%
2/9/2023CM Management LLC110,000$344K0.4%-12.0%0.926%
1/17/2023Wealth Alliance Advisory Group LLC18,751$59K0.0%-25.0%0.158%
11/17/2022Telemetry Investments L.L.C.150,000$489K0.6%-6.3%1.263%
10/25/2022Raymond James & Associates24,000$78K0.0%N/A0.202%
10/12/2022Wealth Alliance Advisory Group LLC25,000$82K0.0%N/A0.210%
5/9/2022CM Management LLC125,000$511K0.4%+38.9%1.052%
2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085%
2/2/2022CM Management LLC90,000$489K0.4%+39.9%0.758%
11/16/2021Telemetry Investments L.L.C.96,232$716K1.0%+217.7%0.810%
11/15/2021Veritable L.P.25,064$187K0.0%N/A0.211%
11/9/2021Indie Asset Partners LLC29,652$221K0.2%N/A0.250%
11/8/2021CM Management LLC64,327$479K0.4%+543.3%0.542%
8/17/2021Bridgeway Capital Management LLC50,000$501K0.0%N/A0.421%
8/16/2021Telemetry Investments L.L.C.30,293$303K0.4%N/A0.255%
8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025%
8/10/2021CM Management LLC10,000$100K0.1%N/A0.084%
(Data available from 1/1/2016 forward)

GANX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GANX shares?

During the previous two years, 14 institutional investors and hedge funds held shares of Gain Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($523K), Marshall Wace LLP ($498K), Hohimer Wealth Management LLC ($422K), Gotham Asset Management LLC ($342K), Dauntless Investment Group LLC ($240K), Jones Financial Companies Lllp ($212K), and Northern Trust Corp ($183K).Learn more on Gain Therapeutics' institutional investors.

What percentage of Gain Therapeutics' stock is owned by institutional investors?

11.97% of Gain Therapeutics' stock is owned by institutional investors. Learn more on GANX's institutional investor holdings.

Which institutional investors have been buying Gain Therapeutics' stock?

Of the 12 institutional investors that purchased Gain Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hohimer Wealth Management LLC ($330K), Marshall Wace LLP ($172.15K), Dauntless Investment Group LLC ($125.58K), Geode Capital Management LLC ($96.49K), Renaissance Technologies LLC ($72K), Warberg Asset Management LLC ($51.60K), and Kovitz Investment Group Partners LLC ($47.58K).

How much institutional buying is happening at Gain Therapeutics?

Institutional investors have bought a total of 586,190 shares in the last 24 months. This purchase volume represents approximately $1.16M in transactions.

Which of Gain Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Gain Therapeutics stock in the last 24 months: Gotham Asset Management LLC ($176.44K), and Geode Capital Management LLC ($4.55K).

How much institutional selling is happening at Gain Therapeutics?

Institutional investors have sold a total of 180,988 shares in the last 24 months. This volume of shares sold represents approximately $390.93K in transactions.


Related Companies

This page (NASDAQ:GANX) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners
This stock just surpassed Palantir
The media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...
InvestorPlace | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
Tucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...
True Market Insiders | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Alert: Prepare for Trump's Dollar Overhaul
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...
Brownstone Research | Sponsoredtc pixel
Trump’s reported death a hoax
How Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...
Porter & Company | Sponsoredtc pixel
World War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.
Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...
Angel Publishing | Sponsoredtc pixel
Litecoin’s Creator Backs the World’s First Treasury
Bitcoin's corporate adoption story has been written. Litecoin's is just beginning.
The Tomorrow Investor | Sponsoredtc pixel